Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Model for end-stage liver disease exception points for treatment-responsive hepatocellular carcinoma.

Literature DB >> 31041039

Model for end-stage liver disease exception points for treatment-responsive hepatocellular carcinoma.

Neehar D Parikh¹, Amit G Singal^2,3.

Abstract

Entities: Disease

Year: 2016 PMID： 31041039 PMCID： PMC6490268 DOI： 10.1002/cld.545

Source DB: PubMed Journal: Clin Liver Dis (Hoboken) ISSN： 2046-2484

Keyword Cloud
Cited

× No keyword cloud information.

6 in total

1. Pre-transplant alpha-fetoprotein is associated with post-transplant hepatocellular carcinoma recurrence mortality.

Authors: Nadim Mahmud; Binu John; Tamar H Taddei; David S Goldberg
Journal: Clin Transplant Date: 2019-06-25 Impact factor: 2.863

Review 2. Treatment Options for Early-Stage Hepatocellular Carcinoma.

Authors: Nora E Tabori; Gajan Sivananthan
Journal: Semin Intervent Radiol Date: 2020-12-11 Impact factor: 1.513

3. Liver transplant for hepatocellular carcinoma in the United States: Evolving trends over the last three decades.

Authors: Marc Puigvehí; Dana Hashim; Philipp K Haber; Amreen Dinani; Thomas D Schiano; Amon Asgharpour; Tatyana Kushner; Gaurav Kakked; Parissa Tabrizian; Myron Schwartz; Ahmet Gurakar; Douglas Dieterich; Paolo Boffetta; Scott L Friedman; Josep M Llovet; Behnam Saberi
Journal: Am J Transplant Date: 2019-10-11 Impact factor: 8.086

Model for end-stage liver disease exception points for treatment-responsive hepatocellular carcinoma.

1. Pre-transplant alpha-fetoprotein is associated with post-transplant hepatocellular carcinoma recurrence mortality.

Review 2. Treatment Options for Early-Stage Hepatocellular Carcinoma.

3. Liver transplant for hepatocellular carcinoma in the United States: Evolving trends over the last three decades.

4. Nonalcoholic fatty liver disease-related hepatocellular carcinoma growth rates and their clinical outcomes.

Review 5. Embolotherapeutic Strategies for Hepatocellular Carcinoma: 2020 Update.

Review 6. Role of Pretransplant Treatments for Patients with Hepatocellular Carcinoma Waiting for Liver Transplantation.